RxDoctor Payments Data

Robert Nocerini, MD

Pain Medicine · Plano, TXNPI 1164451761

Payments from drug & device makers

$2,982in general payments, 2019–2025

Across 66 payments — averaging $45.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertiflex, Inc.$854
  • SPR Therapeutics, Inc$572
  • Abbott$421
  • Boston Scientific$342
  • Medtronic$288
  • Stryker$141
  • plus $365 from 7 others

What the payments were for

  • Travel & lodging$55218%
  • Food & beverage$2,43082%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vertiflex, Inc.9$854
SPR Therapeutics, Inc10$572
Abbott9$421
Boston Scientific14$342
Medtronic(2 entities)10$288
Stryker2$141
Trice Medical, Inc.2$133
Nalu Medical, Inc.4$57
Wound Management Technologies, Inc1$55
Globus Medical1$48
Scilex Pharmaceuticals Inc.2$32
Spinal Simplicity, LLC1$25
Amgen1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,982 in reported general payments places this provider in the 45th percentile of 583 pain medicine providers in Texas.

See all pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$113,940
Medicare patients
124
Services billed
2,115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine123$24,952
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen449$13,521
Pregabalin197$7,244
SymproicNaldemedine Tosylate12$5,466
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen111$3,368
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl83$2,660
Gabapentin166$2,279
Duloxetine Hcl171$2,018
Lidocaine21$1,924
Oxycodone Hcl79$1,693
Morphine Sulfate ErMorphine Sulfate56$1,640
Naloxone Hcl16$923
Hydromorphone Hcl47$899
Buprenorphine Hcl46$884
Tramadol Hcl102$825

Paid to pharmacies, not to this prescriber.

Other pain medicine in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →